Neuro

Fluid Biomed Inc. Announces World’s First Implantation of Polymer-based Neurovascular Stent in Human Patients

First-in-Human Clinical Safety Trial is Successfully Launched using ReSolv™, the Unique Polymer-Based Flow-Diverting Stent Designed to Treat Brain Aneurysms Company Advisory Board Expands to Include Respected Medical Key Opinion Leader and Medtech Entrepreneur CALGARY, AB, June 1, 2023 /PRNewswire/ – Fluid Biomed Inc., a medical device company developing ReSolv™, the world’s first hybrid […]

Pharmazz, Inc. Announces Marketing Approval of Sovateltide in India for Acute Cerebral Ischemic Stroke Patients

The proportion of acute cerebral ischemic stroke patients with the mRS of 0-2 on day 90 post-randomization was statistically significant (p=0.002) Sovateltide is a first-in-class drug that increases blood flow, inhibits apoptosis, and induces neurovascular remodeling WILLOWBROOK, Ill., May 31, 2023 (GLOBE NEWSWIRE) — Pharmazz, Inc. (“Pharmazz” or the “Company”), […]

EOSOLUTIONS CORP. ANNOUNCES THE FULL COMMERCIAL LAUNCH OF THE DR. BANNER BALLOON GUIDE CATHETER: A BREAKTHROUGH BALLOON GUIDE CATHETER WITH UNMATCHED FEATURES FOR NEUROVASCULAR PROCEDURES

PEMBROKE PINES, Fla., May 24, 2023 /PRNewswire/ — EOSolutions Corp., a pioneering medical technology company focused on delivering high-quality catheter solutions, is proud to introduce the Dr. Banner, Balloon Guide Catheter (BGC). Developed in collaboration with InNeuroCo, a leading design, consulting, and contract manufacturing group, Dr. Banner sets new benchmarks in catheter technology, […]

Clinical Trial Enrollment Complete for Study of MIVI Q™ Revascularization System that Treats Acute Ischemic Stroke

EDEN PRAIRIE, Minn., May 3, 2023 /PRNewswire/ — MIVI Neuroscience, Inc., innovator of next-generation neurointerventional medical devices, today announced that it has completed enrollment in the company’s clinical trial to assess the safety and effectiveness of the Q™ Revascularization System for the treatment of acute ischemic stroke (EVAQ Trial). The EVAQ Trial enrolled […]

ConcertAI’s TeraRecon Adds the Releases of an AI-Assisted Clinical Suite Solution, Neuro Suite to Provide Comprehensive Solutions for Neurological Disorders

CAMBRIDGE, Mass., April 28, 2023 /PRNewswire/ — ConcertAI’s TeraRecon, the advanced visualization and clinical AI SaaS category leader, has announced the release of its AI-driven clinical suite, Neuro Suite. Purpose-built for disease triage, differential diagnostic insights, and care activation in many neurological disease states such as neuro-oncology, dementia, multiple sclerosis, and more, […]

egnite Announces Portfolio Expansion to Reduce Stroke Risk in Atrial Fibrillation Patients

Expansion leverages a custom module to help health systems identify patients eligible for lifesaving therapy ALISO VIEJO, Calif.–(BUSINESS WIRE)–egnite, Inc., a leading digital health company for cardiovascular care, announces the expansion of its portfolio with the integration of a custom module designed to help physicians and health systems identify patients […]

Route 92 Medical Receives the First FDA Clearance for a Complete Stroke Treatment System

The FreeClimb 70 Reperfusion System, powered by the Tenzing 7 delivery catheter, enables neurointerventionalists to address critical unmet needs in ischemic stroke treatment SAN MATEO, Calif., April 24, 2023 (GLOBE NEWSWIRE) — Route 92 Medical, Inc., a privately held medical technology company dedicated to improving outcomes for patients undergoing neurovascular […]

Zylox-Tonbridge enters into strategic cooperation with Hicicare for innovative Chinese vascular guidewires solutions

HANGZHOU, China, April 23, 2023 /PRNewswire/ — Zylox-Tonbridge Medical Technology Co., Ltd. (2190. HK, the “Company”) announced the signing of a strategic agreement with Guangdong Hicicare Science Co., Ltd. (“Hicicare”). With the collaboration, Zylox-Tonbridge and Hicicare plan to introduce and help accelerate the commercialization of co-branded vascular guidewire products in the neuro- […]

Cercare Medical brings their Neurovascular Clinical Workflows into ConcertAI’s TeraRecon Eureka Clinical AI Platform in new Partnership

New partnership incorporates latest perfusion technology into neurological CT and MR imaging CAMBRIDGE, Mass., April 20, 2023 /PRNewswire/ — The Eureka Clinical AI platform from ConcertAI’s TeraRecon provides clinicians with the state-of-the-artand deep learning technologies to deliver next-level CT and MR imaging through Cercare Perfusion, a fully-automated, simple-to-use, patient-specific perfusion software. Brain […]